Similar articles

• Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.

  Hughes RC, Polgar JG, Weightman D, Walton JN. Hughes RC, et al. Br Med J. 1971 May 29;2(5760):487-91. doi: 10.1136/bmj.2.5760.487. Br Med J. 1971. PMID: 5579489 Free PMC article. Clinical Trial.
• Levadopa and anticholinergic drugs in Parkinsonism.

  Sourkes T. Sourkes T. Br Med J. 1971 Sep 18;3(5776):703-4. doi: 10.1136/bmj.3.5776.703-b. Br Med J. 1971. PMID: 5569560 Free PMC article. No abstract available.
• Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).

  [No authors listed] [No authors listed] JAMA. 1971 Mar 22;215(12):1969-72. doi: 10.1001/jama.1971.03180250061016. JAMA. 1971. PMID: 4396120 No abstract available.
• The treatment of parkinsonism. Current concepts.

  Yahr MD. Yahr MD. Med Clin North Am. 1972 Nov;56(6):1377-92. doi: 10.1016/s0025-7125(16)32327-6. Med Clin North Am. 1972. PMID: 4117524 Review. No abstract available.
• The pharmacotherapy of Parkinsonism.

  Pinder RM. Pinder RM. Prog Med Chem. 1972;9(2):192-274. Prog Med Chem. 1972. PMID: 4147180 Review. No abstract available.